Skip to content
NYSE: IGC | Borse Berlin: IGS1.BE | Frankfurt: IGS1
IGC

IGC

India Globalization Capital Inc.

  • Home
  • Life Sciences
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • XBRL Files
    • Leadership
    • Governance
    • Letter to Our Stockholders

Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients

February 22, 2021February 22, 2021 by Alejandro
Posted in News and Filings, Press Releases

Post navigation

← IGC Reports Financial Results for December 31, 2020 Quarter
IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain →

Site Map

  • Home
  • Life Sciences
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • XBRL Files
    • Leadership
    • Governance
    • Letter to Our Stockholders

Contact

IGC
Potomac, MD, United States

info@igcinc.us
301-983-0998